SCNX — Scienture Holdings Share News
0.000.00%
Last trade - 00:00- $5.73m
- $8.72m
- $0.43m
Brief: TRxADE Health Inc Announces Closing Of Acquisition Of Superlatus Inc
TRxADE Health Inc expected to post a loss of 75 cents a share - Earnings Preview
Brief: Trxade Health, Amends Definitive Merger Agreement With Superlatus
Brief: TRxADE Health On July 7 Received Written Notice From Nasdaq Stating That Co Has Regained Compliance With Nasdaq Listing Rule 5550(A)(2)
Brief: Superlatus Inc And TRxADE HEALTH Inc Sign Definitive Merger Agreement
Brief: TRxADE Health Says On June 23, Nasdaq Said Co Not In Compliance With Nasdaq's Listing Rules 5550(A)(4)
Brief: TRxADE Health Says Superlatus Inc To Combine With TRxADE Health
Brief: Superlatus To Combine With TRxADE Health To Create A Global Food Consolidation Platform
Brief: Trxade Health, Inc.’S Board Of Directors Approves Reverse Stock Split
TRxADE Health Inc reports results for the quarter ended in March - Earnings Summary
Brief: Trxade Health Reports First Quarter Gross Margin Of 69% And Q1 2023 Financial Results
TRxADE Health Inc expected to post a loss of 4 cents a share - Earnings Preview
TRxADE Health Inc expected to post a loss of 4 cents a share - Earnings Preview
Brief: TRxADE Health Inc Says On April 5, Received Letter From Nasdaq Granting Co Exception To Permit Continued Listing On Nasdaq
TRxADE Health Inc reports results for the quarter ended in December - Earnings Summary
TRxADE Health Inc expected to post a loss of 6 cents a share - Earnings Preview
Brief: Trxade Health Inc Says Janet Huffman Resigned As Acting CFO
Brief: Trxade Health Inc - Effective Feb 27, Janet Huffman, Chief Financial Officer Of Notified Co Of Termination Of Her Offer Letter Dated February 3
U.S. STOCKS ON THE MOVE-Manchester United, DoorDash, Deere & Co